ATE444354T1 - Attenuierter circovirus - Google Patents

Attenuierter circovirus

Info

Publication number
ATE444354T1
ATE444354T1 AT02740122T AT02740122T ATE444354T1 AT E444354 T1 ATE444354 T1 AT E444354T1 AT 02740122 T AT02740122 T AT 02740122T AT 02740122 T AT02740122 T AT 02740122T AT E444354 T1 ATE444354 T1 AT E444354T1
Authority
AT
Austria
Prior art keywords
circovirus
attenuate
attenuated circovirus
mutation
animal
Prior art date
Application number
AT02740122T
Other languages
English (en)
Inventor
Glenn Browning
Michelle Peters
Kelly Tivendale
Peter Scott
Hayley Brown
Brendan Crabb
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne filed Critical Univ Melbourne
Application granted granted Critical
Publication of ATE444354T1 publication Critical patent/ATE444354T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02740122T 2001-06-14 2002-06-14 Attenuierter circovirus ATE444354T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR5674A AUPR567401A0 (en) 2001-06-14 2001-06-14 Circovirus vaccines
PCT/AU2002/000787 WO2002102999A1 (en) 2001-06-14 2002-06-14 Attenuated circovirus

Publications (1)

Publication Number Publication Date
ATE444354T1 true ATE444354T1 (de) 2009-10-15

Family

ID=3829647

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02740122T ATE444354T1 (de) 2001-06-14 2002-06-14 Attenuierter circovirus

Country Status (10)

Country Link
US (1) US7442378B2 (de)
EP (1) EP1407007B1 (de)
JP (1) JP4481637B2 (de)
CN (1) CN100547070C (de)
AT (1) ATE444354T1 (de)
AU (2) AUPR567401A0 (de)
BR (1) BR0210429A (de)
DE (1) DE60233875D1 (de)
ES (1) ES2334646T3 (de)
WO (1) WO2002102999A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040062775A1 (en) 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
AU2006285850A1 (en) 2005-08-29 2007-03-08 Japan Science And Technology Agency Antibody produced using ostrich and method for production thereof
CN101374547A (zh) * 2005-12-22 2009-02-25 财团法人化学及血清疗法研究所 卵内接种用疫苗
WO2008127279A2 (en) * 2006-10-05 2008-10-23 Cerebus Biologicals, Inc. Methods for treating, preventing and diagnosing porcine ttv infection
JP5554231B2 (ja) * 2007-06-13 2014-07-23 コモンウェルス サイエンティフィック アンドインダストリアル リサーチ オーガナイゼーション トリの生産形質の改変
EP3049106A1 (de) 2013-09-25 2016-08-03 Zoetis Services LLC Divergente impfstoffzusammensetzung gegen pcv2b und verfahren zur verwendung
CN106018302A (zh) * 2016-07-04 2016-10-12 云南农业大学 莴苣在丝核菌毒素定性和定量检测中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981502A (en) * 1990-09-12 1999-11-09 Leadd B.V. Methods and compositions for inducing apoptosis in tumor cells
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
NL9301272A (nl) 1993-07-20 1995-02-16 Aesculaap Bv Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.
ZA918426B (en) 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
US5789567A (en) * 1994-07-06 1998-08-04 Cornell Research Foundation, Inc. Chicken infectious anemia virus vaccine
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
NZ309172A (en) 1995-06-07 1999-11-29 Leadd B Neutralizing conformational epitopes of chicken anemia virus

Also Published As

Publication number Publication date
JP4481637B2 (ja) 2010-06-16
JP2004535194A (ja) 2004-11-25
ES2334646T3 (es) 2010-03-15
US20060257424A1 (en) 2006-11-16
US7442378B2 (en) 2008-10-28
EP1407007B1 (de) 2009-09-30
EP1407007A1 (de) 2004-04-14
AUPR567401A0 (en) 2001-07-12
AU2002315560B2 (en) 2007-04-26
CN1537162A (zh) 2004-10-13
CN100547070C (zh) 2009-10-07
DE60233875D1 (de) 2009-11-12
EP1407007A4 (de) 2005-05-18
BR0210429A (pt) 2004-10-13
WO2002102999A1 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
ATE297757T1 (de) Chimäre impfstoffe gegen flaviviren
ATE378403T1 (de) Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern
CY1118901T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
HUP0301659A2 (hu) Kukorica cellulóz-szintetázok és alkalmazásuk
EA200600746A1 (ru) Конструкции нуклеиновых кислот
ATE444354T1 (de) Attenuierter circovirus
DK0870046T3 (da) Levende rekombinant vaccine som indeholder felint herpesvirus type 1, især til behandling af felin infektiös peritonitis
NL1021066A1 (nl) Met silaan gemodificeerde polyvinylacetalen.
DE602004023757D1 (de) Methode zur reinigung von fsh
CY1114614T1 (el) Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα
ATE346958T1 (de) Universelles nachweissystem für mehrere varianten
BR9916507A (pt) Proteìnas
BG97042A (bg) Метод за получаване на растения,резистентни към атаките на sсlеrотiniа sсlеrотiоruм,чрез внасяне на ген,кодиращ оксалатоксидаза
DE69013547D1 (de) N-Hydroxycarbyloxy-gehinderte, phosphorsubstituierte Amine verwendbar als Stabilisatoren gegen Lichteinwirkung.
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
ATE442441T1 (de) Virale expressionsvektoren für pflanzen
DK0778894T3 (da) Vaccine mod infektiös felin peritonitis
NO20020064L (no) Chlamysin B antibakterielt protein, gen som koder for dette samt et ekspresjonssystem for dette
ATE346536T1 (de) Bürstensystem
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
DE59812231D1 (de) Sauggerätevorsatz, bspw. zur Feuchtreinigung von Flächen
TH50268A3 (th) การปลูกวัคซีนเพสติไวรัส
BR0105537B1 (pt) aparelho de bóia de carburador.
ATE409747T1 (de) Mit wt1 interagierendes protein, wtip

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties